Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript

X4 Pharmaceuticals, Inc (XFOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in X4 PHARMACEUTICALS, INC.
01/13/2023 SC 13G Empery Asset Management, LP reports a 5.1% stake in X4 Pharmaceuticals, Inc.
01/19/2022 SC 13G Lincoln Park Capital Fund, LLC reports a 6.4% stake in X4 PHARMACEUTICALS, INC.
11/17/2021 SC 13G Point72 Asset Management, L.P. reports a 5.6% stake in X4 Pharmaceuticals, Inc.
02/02/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/30/2020 SC 13G Ikarian Capital, LLC reports a 5.1% stake in X4 PHARMACEUTICALS, INC.
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/17/2019 SC 13G EcoR1 Capital, LLC reports a 7.2% stake in X4 Pharmaceuticals, Inc.
12/09/2019 SC 13G Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc.
05/10/2019 SC 13G FMR LLC reports a 10.5% stake in X4 PHARMACEUTICALS INC
04/23/2019 SC 13G BIOTECHNOLOGY VALUE FUND L P reports a 10% stake in X4 Pharmaceuticals, Inc.
04/22/2019 SC 13G Cormorant Asset Management, LLC reports a 7.4% stake in X4 Pharmaceuticals, Inc.
04/19/2019 SC 13G ORBIMED ADVISORS LLC reports a 9.8% stake in X4 PHARMACEUTICALS, INC.
04/16/2019 SC 13G Flynn James E reports a 6.7% stake in X4 Pharmaceuticals, Inc.
03/15/2019 SC 13G Bill & Melinda Gates Foundation reports a 1.8% stake in X4 Pharmaceuticals, Inc.
02/13/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/11/2017 SC 13G FMR LLC reports a 10.8% stake in ARSANIS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy